KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Accured Expenses (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 16 years of Change in Accured Expenses data on record, last reported at -$15.1 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 59.61% year-over-year to -$15.1 million; the TTM value through Dec 2025 reached -$19.3 million, down 762.26%, while the annual FY2025 figure was -$19.3 million, 762.26% down from the prior year.
  • Change in Accured Expenses reached -$15.1 million in Q4 2025 per ACAD's latest filing, up from -$25.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $54.9 million in Q3 2023 and bottomed at -$37.4 million in Q4 2024.
  • Average Change in Accured Expenses over 5 years is $3.5 million, with a median of $6.4 million recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: soared 1355.39% in 2022, then plummeted 292.7% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$8.1 million in 2021, then plummeted by 94.26% to -$15.7 million in 2022, then skyrocketed by 342.41% to $38.1 million in 2023, then crashed by 198.01% to -$37.4 million in 2024, then skyrocketed by 59.61% to -$15.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$15.1 million in Q4 2025, -$25.5 million in Q3 2025, and $19.4 million in Q2 2025.